North America's Dominance in Biosimilars and the Growth Surge in Asia-Pacific

FAQ's

Answer : According to Precedence Research, the global healthcare contract research organization market was valued at USD 41.6 billion in 2020 and is anticipated to hit over USD 75.9 billion by 2030.

Answer : The global healthcare contract research organization market is expected to drive growth at a CAGR of 6.2% from 2022 to 2030.

Answer : The rising prevalence of various chronic diseases and rapidly growing geriatric population is boosting the demand for the various new and innovative life-saving drugs across the globe.

Answer : The major players operating in the healthcare contract research organization market are QVIA, LabCorp, Charles River Laboratories, WuXiAppTec, Syneos Health, Parexel International, PPD, ICON Plc, Medpace Holdings, SGS, PSI CRO AG, Axcent Advanced Analytics, BIO Agile Therapeutics, Firma Clinical Research, and Acculab Life Sciences.

Answer : North America dominated the global healthcare contract research organization market in 2020 and will lead the market in next decade.

Business Email Address

Please enter a valid business email address.

Phone Number

Please enter phone number.

Need Custom Insights? Share your Requirement.

Please enter comment for Research Experts Help.

3247

Invalid Captcha!

North America's Dominance in Biosimilars and the Growth Surge in Asia-Pacific

FAQ's

Question 1:What is the current size of healthcare contract research organization market?

Question 2:What is the CAGR of global healthcare contract research organization market?

Question 3:Which are the driving factors of the healthcare contract research organization market?

Question 4:Who are the major players operating in the healthcare contract research organization market?

Question 5:Which region will lead the global healthcare contract research organization market?

Get a Sample of this Report

Ready to Transform Your Financial Management?